Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_636deb9e85d4f285290de001e39aa93e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1013ed7ff19761797ce87925554c543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5a82647325dc90a112bc16fb1229972 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
filingDate |
2009-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beb74581d2cf35ac60e2c75042920dca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22362e9471323ecda9030edd82300e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58bc2a5ca0ebd4ca32cd36a6aa964024 |
publicationDate |
2009-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009275513-A1 |
titleOfInvention |
Composition and method for preparing plasminogen |
abstract |
Disclosed is both a method for preparing a plasminogen and a method for preparing a reversibly inactive acidified plasmin by activating the plasminogen. The prepared plasminogen is typically purified from a fraction obtained in the separation of immunoglobulin from Fraction II+III chromatographic process and eluted at a low pH. The prepared plasmin is isolated and stored with a low pH-buffering capacity agent to provide a substantially stable formulation. The reversibly inactive acidified plasmin may be used in the administration of a thrombolytic therapy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389515-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11207387-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012009650-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111909920-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206410-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105730-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478535-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547746-B2 |
priorityDate |
1999-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |